Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP818011.RAD9_q55WnTWu6UImAi9My4r87OLB8AryQ-Fl4-d_YOAw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP818011.RAD9_q55WnTWu6UImAi9My4r87OLB8AryQ-Fl4-d_YOAw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP818011.RAD9_q55WnTWu6UImAi9My4r87OLB8AryQ-Fl4-d_YOAw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP818011.RAD9_q55WnTWu6UImAi9My4r87OLB8AryQ-Fl4-d_YOAw130_provenance.
- NP818011.RAD9_q55WnTWu6UImAi9My4r87OLB8AryQ-Fl4-d_YOAw130_assertion description "[Doxorubicin (ADR) is successfully used to treat breast cancer, however, it is often associated with the acquired resistance of breast cancer cells which eliminates the therapeutic efficiency of ADR, leading to relapse and a poorer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP818011.RAD9_q55WnTWu6UImAi9My4r87OLB8AryQ-Fl4-d_YOAw130_provenance.
- NP818011.RAD9_q55WnTWu6UImAi9My4r87OLB8AryQ-Fl4-d_YOAw130_assertion evidence source_evidence_literature NP818011.RAD9_q55WnTWu6UImAi9My4r87OLB8AryQ-Fl4-d_YOAw130_provenance.
- NP818011.RAD9_q55WnTWu6UImAi9My4r87OLB8AryQ-Fl4-d_YOAw130_assertion SIO_000772 23546450 NP818011.RAD9_q55WnTWu6UImAi9My4r87OLB8AryQ-Fl4-d_YOAw130_provenance.
- NP818011.RAD9_q55WnTWu6UImAi9My4r87OLB8AryQ-Fl4-d_YOAw130_assertion wasDerivedFrom befree-20140225 NP818011.RAD9_q55WnTWu6UImAi9My4r87OLB8AryQ-Fl4-d_YOAw130_provenance.
- NP818011.RAD9_q55WnTWu6UImAi9My4r87OLB8AryQ-Fl4-d_YOAw130_assertion wasGeneratedBy ECO_0000203 NP818011.RAD9_q55WnTWu6UImAi9My4r87OLB8AryQ-Fl4-d_YOAw130_provenance.
- befree-20140225 importedOn "2014-02-25" NP818011.RAD9_q55WnTWu6UImAi9My4r87OLB8AryQ-Fl4-d_YOAw130_provenance.